Eton Pharmaceuticals, Inc.: capex
| Value | {"amount": 14000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-03-31 |
| Status | current |
| Entity | Eton Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:30:32.543730+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d8f844f4-649a-43ec-82c5-51995e5d43e3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-24-015697Retrieved: 2026-08-19T17:30:32.543730+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001710340/capex/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d8f844f4-649a-43ec-82c5-51995e5d43e3
History
- no predecessors — first report